{
  "DOI": "10.1038/s41431-019-0368-7",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-019-0368-7",
  "alternative-id": [
    "368"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "10 October 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "14 December 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "29 January 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "7 March 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-7370-3936",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Liddicoat",
      "given": "Johnathon",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Liddell",
      "given": "Kathleen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "McCarthy",
      "given": "Arlie H.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hogarth",
      "given": "Stuart",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aboy",
      "given": "Mateo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nicol",
      "given": "Dianne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Patton",
      "given": "Simon",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hopkins",
      "given": "Michael M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        3,
        7
      ]
    ],
    "date-time": "2019-03-07T14:04:11Z",
    "timestamp": 1551967451000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T20:59:30Z",
    "timestamp": 1684616370000
  },
  "funder": [
    {
      "name": "The Wellcome Trust Institutional Strategic Support Fund"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        8
      ]
    ],
    "date-time": "2024-03-08T12:23:24Z",
    "timestamp": 1709900604781
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2019,
        3,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2019,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            3,
            7
          ]
        ],
        "date-time": "2019-03-07T00:00:00Z",
        "timestamp": 1551916800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-019-0368-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0368-7",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0368-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "997-1007",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2019,
        3,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        3,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "368_CR1",
      "unstructured": "Kevles DJ, Hood L Reflections. In Kevles JD, Hood L (eds.) The Code of Codes: Scientific and Social Issues in the Human Genome Project. Harvard University Press: Cambridge, MA, US, 1992, pp 300–28."
    },
    {
      "DOI": "10.1146/annurev-genet-112414-054731",
      "author": "JS Sherkow",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Annu Rev Genet",
      "key": "368_CR2",
      "unstructured": "Sherkow JS, Greely HT. The history of patenting genetic material. Annu Rev Genet. 2015;49:161–82.",
      "volume": "49",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nbt.3719",
      "author": "M Aboy",
      "doi-asserted-by": "publisher",
      "first-page": "1119",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR3",
      "unstructured": "Aboy M, Liddell K, Liddicoat J, Crespo C. Myriad’s impact on gene patents. Nat Biotechnol. 2016;34:1119–23.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1038/415577a",
      "author": "J Merz",
      "doi-asserted-by": "publisher",
      "first-page": "577",
      "journal-title": "Nature",
      "key": "368_CR4",
      "unstructured": "Merz J, Kriss A, Leonard D, Cho M. Diagnostic testing fails the test. Nature. 2002;415:577–9.",
      "volume": "415",
      "year": "2002"
    },
    {
      "DOI": "10.1038/458407a",
      "author": "S Gaisser",
      "doi-asserted-by": "publisher",
      "first-page": "407",
      "journal-title": "Nat",
      "key": "368_CR5",
      "unstructured": "Gaisser S, Hopkins MM, Liddell K, Zika E, Ibarreta D. The phantom menace of gene patents. Nat. 2009;458:407–8.",
      "volume": "458",
      "year": "2009"
    },
    {
      "DOI": "10.1071/AH13029",
      "author": "D Nicol",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "journal-title": "J Aust Health Rev",
      "key": "368_CR6",
      "unstructured": "Nicol D, Liddicoat J. Do patents impede the provision of genetic tests in Australia? J Aust Health Rev. 2013;37:281–5.",
      "volume": "37",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nbt1009-903",
      "author": "I Huys",
      "doi-asserted-by": "publisher",
      "first-page": "903",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR7",
      "unstructured": "Huys I, Berthels N, Matthijs G, Van Overwalle G. Legal uncertainty in the area of genetic diagnostic testing. Nat Biotechnol. 2009;27:903–9.",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nrg3255",
      "author": "I Huys",
      "doi-asserted-by": "publisher",
      "first-page": "441",
      "journal-title": "Nat Rev Genet",
      "key": "368_CR8",
      "unstructured": "Huys I, Matthijs M, Van Overwalle G. The fate and future of patents on human genes and genetic diagnostic methods. Nat Rev Genet. 2012;13:441–8.",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201503",
      "author": "B Verbeure",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Eur J Hum Genet",
      "key": "368_CR9",
      "unstructured": "Verbeure B, Matthijs G, Van Overwalle G. Analysing DNA patents in relation with diagnostic genetic testing. Eur J Hum Genet. 2006;14:26–33.",
      "volume": "14",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S1525-1578(10)60444-8",
      "author": "MK Cho",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "J Mol Diagn",
      "key": "368_CR10",
      "unstructured": "Cho MK, Illangasekare S, Weaver M, Leonard D, Merz J. Effects of patents and licenses on the Provision of Clinical Genetic Testing Services. J Mol Diagn. 2003;5:3–5.",
      "volume": "5",
      "year": "2003"
    },
    {
      "author": "US Secretary’s Advisory Committee on Genetics, Health and Society.",
      "key": "368_CR11",
      "unstructured": "US Secretary’s Advisory Committee on Genetics, Health and Society. Gene patents and licensing practices and their impact on patient access to genetic tests (SACGHS). MD, USA: Bethesda; 2010.",
      "volume-title": "Gene patents and licensing practices and their impact on patient access to genetic tests (SACGHS)",
      "year": "2010"
    },
    {
      "DOI": "10.1126/science.299.5609.1021",
      "author": "JP Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "1021",
      "journal-title": "Science",
      "key": "368_CR12",
      "unstructured": "Walsh JP, Arora A, Cohen WM. Working through the patent problem. Science. 2003;299:1021.",
      "volume": "299",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.respol.2007.04.006",
      "author": "JP Walsh",
      "doi-asserted-by": "publisher",
      "first-page": "1184",
      "journal-title": "Res Pol",
      "key": "368_CR13",
      "unstructured": "Walsh JP, Cohen WM, Cho C. Where excludability matters: material versus intellectual property in academic biomedical research. Res Pol. 2007;36:1184–203.",
      "volume": "36",
      "year": "2007"
    },
    {
      "DOI": "10.1186/gm487",
      "author": "Ilse R Wiechers",
      "doi-asserted-by": "publisher",
      "first-page": "83",
      "issue": "9",
      "journal-title": "Genome Medicine",
      "key": "368_CR14",
      "unstructured": "Wiechers IR, Perin NC, Cook-Deegan R. The emergence of commercial genomics: analysis of the rise of the biotechnology subsector during the Human Genome Project, 1990 to 2004. Gene Med. 2013;5:83.",
      "volume": "5",
      "year": "2013"
    },
    {
      "author": "C Hansen",
      "key": "368_CR15",
      "unstructured": "Hansen C. Dis-Owning Nature: The BRCA Gene Patents and the Supreme Court. Boston, MA, USA: Speech delivered at Harvard University; 2012.",
      "volume-title": "Dis-Owning Nature: The BRCA Gene Patents and the Supreme Court",
      "year": "2012"
    },
    {
      "key": "368_CR16",
      "unstructured": "Association for Molecular Pathology v. Myriad Genetics, Inc, 133S. Ct. 2107 (2013)."
    },
    {
      "key": "368_CR17",
      "unstructured": "Ariosa Diagnostics Inc v Sequenom Inc, 809F.3d 1282 (Fed Cir, 2015)."
    },
    {
      "key": "368_CR18",
      "unstructured": "Association for Molecular Pathology v US Patent and Trademark Office, 689F.3d 1303 (Fed Cir, 2012)."
    },
    {
      "DOI": "10.1038/nbt.3953",
      "author": "M Aboy",
      "doi-asserted-by": "publisher",
      "first-page": "820",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR19",
      "unstructured": "Aboy M, Liddicoat J, Liddell K, Jordan M, Crespo C. After Myriad, what makes a gene patent claim ‘markedly different from nature? Nat Biotechnol. 2017;35:820–5.",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nbt.3470",
      "author": "CJ Guerrini",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR20",
      "unstructured": "Guerrini CJ, Majumder MA, McGuire AL. Persistent confusion and controversy surrounding gene patents. Nat Biotechnol. 2016;34:145–7.",
      "volume": "34",
      "year": "2016"
    },
    {
      "key": "368_CR21",
      "unstructured": "American Intellectual Property Law Association. AIPLA Legislative Proposal and Report on Patent Eligible Subject Matter (12 May 2017)."
    },
    {
      "key": "368_CR22",
      "unstructured": "United States Patent and Trademark Office. Patent eligible subject matter: report on view and recommendation from the public (July 2017) \n                    https://www.uspto.gov/sites/default/files/documents/101-Report_FINAL.pdf\n                    \n                   (accessed 27 November 2018)."
    },
    {
      "key": "368_CR23",
      "unstructured": "Lundberg, S. Dave Kappos calls for abolition of section 101. Natl Law Rev 2016 \n                    https://www.natlawreview.com/article/dave-kappos-calls-abolition-section-101\n                    \n                   (accessed 27 November 2018)."
    },
    {
      "key": "368_CR24",
      "unstructured": "T0666/05 (Mutation/UNIVERSITY OF UTAH)."
    },
    {
      "DOI": "10.1038/ejhg.2011.76",
      "author": "I Huys",
      "doi-asserted-by": "publisher",
      "first-page": "1104",
      "journal-title": "Eur J Hum Genet",
      "key": "368_CR25",
      "unstructured": "Huys I, Van Overwalle G, Matthijs G. Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law. Eur J Hum Genet. 2011;9:1104–7.",
      "volume": "9",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nbt.2644",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR26",
      "unstructured": "Matthijs G, Huys I, Van Overwalle G, Stoppa-Lyonnet D. The European BRCA patent oppositions and appeals: colouring inside the lines. Nat Biotechnol. 2013;31:704–10.",
      "volume": "31",
      "year": "2013"
    },
    {
      "key": "368_CR27",
      "unstructured": "Illumina, Inc v. Premaitha Health Plc [2017] EWHC 2930 (Pat)."
    },
    {
      "key": "368_CR28",
      "unstructured": "Rezeptortyrosinkinase, X ZR 141/13 (19 January 2016)."
    },
    {
      "DOI": "10.1007/s40319-018-0675-5",
      "doi-asserted-by": "crossref",
      "key": "368_CR29",
      "unstructured": "Translation by Allison Felmy. Receptor Tyrosine Kinase. Decision of the Federal Supreme Court (Bundesgerichtshof, X ZR 141/13, 19 January 2016). Int Review Intellect Prop Compet Law. 2016;49:221–30."
    },
    {
      "key": "368_CR30",
      "unstructured": "European Patent Office, Guidelines for Examination, Part G, Chp II, 4.2.1.3 Diagnostics methods (November 2018)."
    },
    {
      "key": "368_CR31",
      "unstructured": "G1/04 (Diagnostic methods) of 16 December 2005."
    },
    {
      "DOI": "10.1093/bmb/ldy009",
      "author": "JS Sherkow",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "journal-title": "Br Med Bull",
      "key": "368_CR32",
      "unstructured": "Sherkow JS, Abbott R. Fortune and hindsight: gene patents’ muted effect on medical practice. Br Med Bull. 2018;1:37–45.",
      "volume": "1",
      "year": "2018"
    },
    {
      "key": "368_CR33",
      "unstructured": "The 100,000 genomes project (Houses of Parliament, Parliamentary Office of Science \u0026 Technology, PostNote, September 2015)."
    },
    {
      "key": "368_CR34",
      "unstructured": "Global Transformational Health Research Team. Western European Molecular Diagnostics Market, 2015 Forecast to 2020 (Frost \u0026 Sullivan, Jan 2017)."
    },
    {
      "key": "368_CR35",
      "unstructured": "Bultman, M. Patent owners taking global view in enforcement efforts (Law360, New York) \n                    https://www.law360.com/articles/1064658/patent-owners-taking-global-view-in-enforcement-efforts?nl_pk=b18736c5-bd66-44aa-8f22-c34e76d610cb\u0026utm_source=newsletter\u0026utm_medium=email\u0026utm_campaign=special\n                    \n                   (18 July 2018)."
    },
    {
      "DOI": "10.1097/GIM.0b013e3181fc50bc",
      "author": "N Hawkins",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "journal-title": "Gene Med",
      "key": "368_CR36",
      "unstructured": "Hawkins N. The impact of human gene patents on genetic testing in the United Kingdom. Gene Med. 2011;13:320–4.",
      "volume": "13",
      "year": "2011"
    },
    {
      "key": "368_CR37",
      "unstructured": "Discussions with the corresponding author, Association for Clinical Genomic Sciences Summer Meeting, Birmingham, UK (29 June 2018)."
    },
    {
      "key": "368_CR38",
      "unstructured": "Rezeptortyrosinkinase II, X ZR 124/15 (27 September 2016)."
    },
    {
      "key": "368_CR39",
      "unstructured": "Translation by Allison Felmy, Receptor Tyrosine Kinase II. Decision of the Federal Supreme Court (Bundesgerichtshof, X ZR 124/15, 27 September 2016). Int Review Intellect Prop Compet Law; 49; 23–236."
    },
    {
      "key": "368_CR40",
      "unstructured": "Laboratory Developed Tests (US Food \u0026 Drug Administration, Maryland, US) \n                    https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/laboratorydevelopedtests/default.htm\n                    \n                   (26 March 2018)."
    },
    {
      "DOI": "10.2139/ssrn.3102238",
      "doi-asserted-by": "crossref",
      "key": "368_CR41",
      "unstructured": "Liddell, KL, Liddicoat, J. Should we change EU law to disallow DNA patents? (October 2015) \n                    https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3102238\n                    \n                   (accessed 26 November 2018)."
    },
    {
      "key": "368_CR42",
      "unstructured": "Final report of the expert group on the development and implications of patent law in the field of biotechnology and genetic engineering (17 May 2016, Directorate General Internal Market, Industry, Entrepreneurship and SMEs) \n                    https://ec.europa.eu/docsroom/documents/18604/attachments/1/translations/en/renditions/pdf\n                    \n                   (accessed 27 November 2018)."
    },
    {
      "DOI": "10.1038/nbt.4308",
      "author": "M Aboy",
      "doi-asserted-by": "publisher",
      "first-page": "1146",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR43",
      "unstructured": "Aboy M, Cristina C, Liddell K, Liddicoat J, Jordan M. Was the Myriad decision a ‘surgical strike’ on isolated DNA patents, or does it have wider impacts? Nat Biotechnol. 2018;36:1146–9.",
      "volume": "36",
      "year": "2018"
    },
    {
      "author": "R Sachs",
      "first-page": "1881",
      "journal-title": "UC Dav L Rev",
      "key": "368_CR44",
      "unstructured": "Sachs R. Innovation law and policy: preserving the future of personalized medicine. UC Dav L Rev. 2016;49:1881–940.",
      "volume": "49",
      "year": "2016"
    },
    {
      "author": "RS Eisenberg",
      "first-page": "256",
      "journal-title": "BU J Sci Tech",
      "key": "368_CR45",
      "unstructured": "Eisenberg RS. Diagnostics need not apply. BU J Sci Tech. 2015;21:256–86.",
      "volume": "21",
      "year": "2015"
    },
    {
      "key": "368_CR46",
      "unstructured": "Chao B, Mapes A. An early look at Mayo’s impact on personalized medicine. Patently-O Patent Law Journal 10. 2016."
    },
    {
      "key": "368_CR47",
      "unstructured": "Cornish WR, Llewelyn M, Adcock M. Intellectual Property Rights (IPRs) and Genetics: a study into the impact and management of Intellectual Property Rights within the Healthcare Sector (July 2003) \n                    http://www.phgfoundation.org/report/intellectual-property-rights-and-genetics\n                    \n                   (accessed 22 August 2018)."
    },
    {
      "DOI": "10.1038/nbt.3182",
      "author": "J Liddicoat",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "journal-title": "Nat Biotechnol",
      "key": "368_CR48",
      "unstructured": "Liddicoat J, Whitton T, Nicol D. Are the gene patent storm clouds dissipating? Nat Biotechnol. 2015;33:347–52.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1257/0895330054048650",
      "author": "MA Lemley",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "journal-title": "J Econ Perspect",
      "key": "368_CR49",
      "unstructured": "Lemley MA, Shapiro C. Probabilistic patents. J Econ Perspect. 2005;19:75–98.",
      "volume": "19",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1740-1461.2011.01245.x",
      "author": "RJ Mann",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Empir Leg Stud",
      "key": "368_CR50",
      "unstructured": "Mann RJ, Underweiser M. A new look a patent quality. J Empir Leg Stud. 2012;9:1–32.",
      "volume": "9",
      "year": "2012"
    },
    {
      "author": "JR Allison",
      "first-page": "185",
      "journal-title": "AIPLA QJ",
      "key": "368_CR51",
      "unstructured": "Allison JR, Lemley M. Empirical evidence on the validity of litigated patents. AIPLA QJ. 1998;26:185–275.",
      "volume": "26",
      "year": "1998"
    },
    {
      "DOI": "10.5465/ambpp.2015.17115abstract",
      "doi-asserted-by": "crossref",
      "key": "368_CR52",
      "unstructured": "Henkel, J, Zischka, H. Why most patents are invalid—Extent, reasons, and potential remedies of patent invalidity (December 2015) \n                    http://www.tim.wi.tum.de/fileadmin/w00bcy/www/Research/Publications/Henkel/Henkel_Zischka_2015-12_Patent_Validity.pdf\n                    \n                   (accessed 28 November 2018)."
    },
    {
      "author": "MA Lemley",
      "first-page": "19",
      "journal-title": "Mich St L Rev",
      "key": "368_CR53",
      "unstructured": "Lemley MA. Ignoring patents. Mich St L Rev. 2008;1:19–34.",
      "volume": "1",
      "year": "2008"
    },
    {
      "key": "368_CR54",
      "unstructured": "Illumina and Sequenom pool noninvasive prenatal testing intellectual property and end outstanding patent disputes (Illumina Inc, San Diego, USA) \n                    https://emea.illumina.com/company/news-center/press-releases/2014/1994454.html\n                    \n                   (3 December 2014)."
    }
  ],
  "reference-count": 54,
  "references-count": 54,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-019-0368-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Continental drift? Do European clinical genetic testing laboratories have a patent problem?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "27"
}